Market revenue in 2023 | USD 74.3 million |
Market revenue in 2030 | USD 137.3 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Anti-vegf agents |
Fastest growing segment | Anti-VEGF agents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma |
Key market players worldwide | Pfizer Inc, Alcon Inc, Novartis AG ADR, Bausch Health Companies Inc, Merck & Co Inc, Regeneron Pharmaceuticals Inc, AbbVie Inc, Bayer AG, Genentech, Nicox SA Share from reverse split, Coherus BioSciences Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.
Anti-vegf agents was the largest segment with a revenue share of 32.84% in 2023. Horizon Databook has segmented the Kuwait ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma covering the revenue growth of each sub-segment from 2018 to 2030.
Several multinational and regional pharmaceutical companies are likely to be active in Kuwait’s ophthalmic drugs market, offering a range of ophthalmic drugs to treat conditions such as dry eye syndrome. Some key players in the Kuwait market are AbbVie, Inc., Novartis AG, Santen, Bausch + Lomb, and Merck & Co.
Moreover, rising government campaigns focusing on eye health awareness, early detection, and treatment play a significant role in driving the growth of the ophthalmic drugs market. The country is focusing on improvements in healthcare infrastructure, including the availability of specialized eye care facilities and skilled professionals, which helps in enhancing the accessibility of ophthalmic drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait ophthalmic drugs market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account